Autres thématiques
Veille bibliographique : Autres thématiques
Les articles sont classés du plus ancien au plus récent, n’hésitez pas à utiliser la barre de recherche pour filtrer les résultats par date par exemple.
| Suarez-Almazor ME et al. Immune-Related Adverse Events with the Use of Checkpoint Inhibitors for Immunotherapy of Cancer. Arthritis Rheumatol. 2017 Jan 13 | Lire le résumé |
| Alpizar-Rodriguez, D. et al. The Prevalence of Anticitrullinated Protein Antibodies Increases with Age in Healthy Individuals at Risk for Rheumatoid Arthritis. Clinical Rheumatology 36, no 3 (mars 2017): 677 82. | Lire le résumé |
| Foster HE, et al. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017;76(4):639–46. | Lire le résumé |
| Kim ST et al. Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series. Ann Rheum Dis. 2017 Aug 22 | Lire le résumé |
| Gulani V et al. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017 Jul;16(7):564–70. | Lire le résumé |
| Youngstein T et al. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Rheumatol Oxf Engl. 2017 Aug 23 | Lire le résumé |
| Bullock DR et al. Telemedicine and other care models in pediatric rheumatology: an exploratory study of parents’ perceptions of barriers to care and care preferences. Pediatr Rheumatol Online J. 2017 Jul 11;15(1):55. | Lire le résumé |
| Park JW et al. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Ann Rheum Dis. 2017 Nov 1 | Lire le résumé |
| Ermann J et al. Immune cell profiling to guide therapeutic decisions in rheumatic diseases. Nat Rev Rheumatol. 2015 Sep;11(9):541-51. | Lire le résumé |
| Yamazaki H et al. PREVENT Study Group. Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study. J Rheumatol. 2015 Apr;42(4):614-22 | Lire le résumé |
| Hetlevik SO et al. Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis. 2017 Jan;76(1):159-165 | Lire le résumé |
| Melboucy-Belkhir S et al. Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases: Intracranial Hemorrhage in Immune Thrombocytopenia. Am J Hematol. 2016 Dec;91(12):E499–501 | Lire le résumé |
| Rigante D et al. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. 2015 Apr 8. | Lire le résumé |
| Castelein T et al. IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis? Rheumatology (Oxford). 2015 Jul;54(7):1250-6 | Lire le résumé |
| Grom AA et al. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. mai 2016;12(5):259‑68 | Lire le résumé |
| Lumry W et al. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema. Pediatr Allergy Immunol. 2015 Nov;26(7):674-80 | Lire le résumé |
| Asano J et al. Association Between Immunoglobulin G4-related Disease and Malignancy within 12 Years after Diagnosis: An Analysis after Longterm Followup. J Rheumatol. 2015 Nov;42(11):2135-42 | Lire le résumé |
| Cattalini M et al. Sex Differences in Pediatric Rheumatology. Clin Rev Allergy Immunol. 2017 Aug 28 | Lire le résumé |
| Kay J et al. Consensus-basedrecommendations for the use of biosimilars to treat rheumatological diseases. Ann Rheum Dis. 2017 Sep 2 | Lire le résumé |
| Ermann J et al. Immune cell profiling to guide therapeutic decisions in rheumatic diseases. Nat Rev Rheumatol. 2015 Sep;11(9):541-51 | Lire le résumé |
| Postow M. et al. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.N Engl J Med. 2018 Jan 11;378(2):158-168 | Lire le résumé |
| Nicole W Tsao et al. Risk of preterm delivery and small for gestational age births in women with autoimmune disease using biologics before or during pregnancy: a population based cohort study. Ann Rheum Dis published online on March 7, 2018 | Lire le résumé |
| Das Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, et al. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurology - Neuroimmunology Neuroinflammation. 2018 May | Lire le résumé |
| Jeyaratnam J, Ter Haar NM, Lachmann HJ, Kasapcopur O, Ombrello AK, Rigante D, et al. The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey. Pediatr Rheumatol Online J. 2018 Mar 21;16(1):19. | Lire le résumé |
| Cabrera N, Lega J-C, Kassai B, Wouters C, Kondi A, Cannizzaro E, et al. Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database. Joint Bone Spine [Internet]. 2018 Sep [cited 2018 Oct 24] | Lire le résumé |
| Cuneo BF, Sonesson S-E, Levasseur S, Moon-Grady AJ, Krishnan A, Donofrio MT, et al. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies. Journal of the American College of Cardiology. 2018 Oct;72(16):1940–51. | Lire le résumé |
| Gabeff R, Safar R, Leducq S, Maruani A, Sarrabay G, Touitou I, et al. Successful therapy with secukinumab in a patient with generalized pustular psoriasis carrying homozygous IL36RN p.His32Arg mutation. International Journal of Dermatology. 2019 Jan;58(1):e16–7 | Lire le résumé |
| Mofors J, Eliasson H, Ambrosi A, Salomonsson S, Skog A, Fored M, et al. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero. Ann Rheum Dis. 26 févr 2019;annrheumdis-2018-214406 | Lire le résumé |
| Mofors J, Eliasson H, Ambrosi A, Salomonsson S, Skog A, Fored M, et al. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero. Ann Rheum Dis. mai 2019;78(5):696‐703 | Lire le résumé |
| Spielmann L, Nespola B, Séverac F, Andres E, Kessler R, Guffroy A, et al. Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes. Ann Rheum Dis. 24 mai 2019 ;annrheumdis-2018-214439 | Lire le résumé |
| [1] Kahr WHA,Pluthero FG, Elkadri A, Warner N, Drobac M, Chen CH, et al. Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease. Nat Commun [Internet]. avr 2017 [cité 26 juin 2019];8(1) [2] Brigida I, Zoccolillo M, Cicalese MP, Pfajfer L, Barzaghi F, Scala S, et al. T cell defects in patients with ARPC1B germline mutations account for their combined immunodeficiency. Blood. 25 sept 2018; blood-2018-07-863431 [3] Kuijpers TW, Tool ATJ, van der Bijl I, de Boer M, van Houdt M, de Cuyper IM, et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. J Allergy Clin Immunol. juill 2017;140(1):273 277.e10 [4] Somech R, Lev A, Lee YN, Simon AJ, Barel O, Schiby G, et al. Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in ARPC1B. J Immunol. 15 déc 2017; 199(12):4036 45 [5] Volpi S, Cicalese MP, Tuijnenburg P, Tool ATJ, Cuadrado E, Abu-Halaweh M, et al. A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency. J Allergy Clin Immunol. juin 2019;143(6):2296 9 | Lire le résumé |
| Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, et al. Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases. Ann Rheum Dis. 5 juill 2019;annrheumdis-2018-214472 | Lire le résumé |
| 1. Kontzias A, Zarabi SK, Calabrese C, Wang Y, Judis L, Yao Q, et al. Somatic mosaicism in adult‐onset TNF receptor‐associated periodic syndrome (TRAPS). Mol Genet Genomic Med [Internet]. 10 juill 2019 [cité 22 août 2019]; 2. Labrousse M, Kevorkian-Verguet C, Boursier G, Rowczenio D, Maurier F, Lazaro E, et al. Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review. Crit Rev Clin Lab Sci. 18 août 2018;55(6):432 42. 3. Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L, et al. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis. déc 2014;73(12):2160 7 4. Rowczenio DM, Trojer H, Omoyinmi E, Aróstegui JI, Arakelov G, Mensa-Vilaro A, et al. Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion: GONOSOMAL MOSAICISM OF A TNFRSF1A DELETION IN TRAPS. Arthritis Rheumatol. août 2016;68(8):2044 9 5. 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID): Genoa, Italy. 31 March - 3 April 2019. Pediatr Rheumatol [Internet]. mai 2019 [cité 22 août 2019];17(S1). Abstract P1122, page 90. (Pediatric Rheumatology) | Lire le résumé |
| Schwabbauer ML. Use of the latent image technique to develop and evaluate problem-solving skills. Am J Med Technol. déc 1975;41(12):457 62 | Lire le résumé |
| Fernández-Fernández E, Monjo-Henry I, Bonilla G, Plasencia C, Miranda-Carús M-E, Balsa A, et al. False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign. Rheumatology [Internet]. 18 janv 2020 [cité 20 févr 2020] | Lire le résumé |
| Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, et al. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Ann Intern Med [Internet]. 18 févr 2020 [cité 26 févr 2020]; | Lire le résumé |
| Eloseily E1, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, Beukelman T, Atkinson TP, Cron RQ. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020 Feb;72(2):326-334. | Lire le résumé |
| Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev. mai 2020;19(5):102523 | Lire le résumé |
| Bridges C, Shenk MER, Martin K, Launhardt A. Cutaneous manifestations of childhood Eosinophilic Granulomatosis with Polyangiitis (cEGPA): A case-based review. Pediatr Dermatol [Internet]. 24 mars 2020 [cité 28 mai 2020]; Disponible sur: http://doi.wiley.com/10.1111/pde.14144 | Lire le résumé |
| Manthiram K, Preite S, Dedeoglu F, Demir S, Ozen S, Edwards KM, et al. Common genetic susceptibility loci link PFAPA syndrome, Behçet’s disease, and recurrent aphthous stomatitis. Proc Natl Acad Sci. 9 juin 2020;202002051 | Lire le résumé |
| Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 23 juill 2020;383(4):334‑46 | Lire le résumé |
| Sparks JA, Dellaripa PF, Glynn RJ, Paynter NP, Xu C, Ridker PM, et al. Pulmonary adverse events of low‐dose methotrexate in the randomized double‐blind placebo‐controlled Cardiovascular Inflammation Reduction Trial. Arthritis Rheumatol [Internet]. 2 août 2020 [cité 27 août 2020] | Lire le résumé |
| Liu Y, Zhu L, Wang Z, Zeng Q, Yang F, Gao J, et al. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study. Rheumatology [Internet]. 13 août 2020 [cité 24 sept 2020] | Lire le résumé |
| Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. nov 2020;183(4):968‑981.e7. | Lire le résumé |
| Goel RR, Nakabo S, Dizon BLP, Urban A, Waldman M, Howard L, et al. Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome. J Allergy Clin Immunol [Internet]. août 2020 [cité 26 janv 2021] | Lire le résumé |
| Boudigaard SH, Schlünssen V, Vestergaard JM, Søndergaard K, Torén K, Peters S, et al. Occupational exposure to respirable crystalline silica and risk of autoimmune rheumatic diseases: a nationwide cohort study. Int J Epidemiol [Internet]. 18 janv 2021 [cité 22 févr 2021]; | Lire le résumé |
| Petri M, Elkhalifa M, Li J, Magder LS, Goldman DW. Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy. Arthritis Rheumatol. mars 2020;72(3):448‑53. | Lire le résumé |
| Rosenbaum JT, Costenbader KH, Desmarais J, Ginzler EM, Fett N, Goodman SM, et al. ACR, AAD, RDS, and AAO 2020 Joint Statement on Hydroxychloroquine Use with Respect to Retinal Toxicity. Arthritis Rheumatol [Internet]. 9 févr 2021 [cité 23 févr 2021] | Lire le résumé |
| Ferrada MA, Sikora KA, Luo Y, Wells KV, Patel B, Groarke EM, et al. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients with VEXAS Syndrome. Arthritis Rheumatol [Internet]. 28 mars 2021 [cité 23 avr 2021]; | Lire le résumé |
| Tsuchida N, Kunishita Y, Uchiyama Y, Kirino Y, Enaka M, Yamaguchi Y, et al. Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis. 31 mars 2021;annrheumdis-2021-220089. | Lire le résumé |
| Bourbon E, Heiblig M, Gerfaud-Valentin M, Barba T, Durel CA, Lega J-C, et al. Therapeutic options in Vexas syndrome: insights from a retrospective series. Blood [Internet]. 22 févr 2021 [cité 26 avr 2021] | Lire le résumé |
| Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2. Neurol - Neuroimmunol Neuroinflammation. juill 2021;8(4):e1023. | Lire le résumé |
| Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol. déc 2021;17(12):731‑48 | Lire le résumé |
| Zheng S, Lee PY, Huang Y, Deng W, Huang Z, Huang Q, et al. Clinical characteristics of juvenile gout and treatment response to febuxostat. Ann Rheum Dis. 20 déc 2021;annrheumdis-2021-221762. | Lire le résumé |
| Aeschlimann FA, Misra N, Hussein T, Panaioli E, Soslow JH, Crum K, et al. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registry. J Cardiovasc Magn Reson. déc 2021;23(1):140. | Lire le résumé |
| Moreews M, Le Gouge K, Khaldi-Plassart S, Pescarmona R, Mathieu A-L, Malcus C, et al. Polyclonal expansion of TCR Vb 21.3 + CD4 + and CD8 + T cells is a hallmark of multisystem inflammatory syndrome in children. Sci Immunol. 28 mai 2021;6(59):eabh1516. | Lire le résumé |
| Villacis-Nunez S, Jones K, Jabbar A, Fan L, Moore W, S. Peter A, Henderson M, Xiang Y, S. Kelleman M, Sherry W, Chandrakasan S, E. Oste Mr, Jaggi P, Prahalad S, Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children. JAMA Pediatr . 2022 Mar 28;e220292. doi: 10.1001/jamapediatrics.2022.0292 | Lire le résumé |
| Wiebe E, Huscher D, Schaumburg D, Palmowski A, Hermann S, Buttgereit T, et al. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Ann Rheum Dis. 9 juin 2022;annrheumdis-2022-222339 | Lire le résumé |
| Sacco K, Castagnoli R, Vakkilainen S, Liu C, Delmonte OM, Oguz C, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. mai 2022;28(5):1050‑62 | Lire le résumé |
| Charbit‐Henrion F, Goguyer‐Deschaumes R, Borensztajn K, Mirande M, Berthelet J, Rodrigues‐Lima F, et al. Systemic inflammatory syndrome in children with FARSA deficiency. Clin Genet. mai 2022;101(5‑6):552‑8. | Lire le résumé |
| Del Giudice E, Sota J, Orlando F, Picciano L, Cimaz R, Cantarini L, et al. Off-label use of canakinumab in pediatric rheumatology and rare diseases. Front Med. 18 oct 2022;9:998281 | Lire le résumé |
| Maher TM, Tudor VA, Saunders P, Gibbons MA, Fletcher SV, Denton CP, et al. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial. Lancet Respir Med. nov 2022;S2213260022003599 | Lire le résumé |
| Welzel T, Atkinson A, Schöbi N, Andre MC, Bailey DGN, Blanchard-Rohner G, Buettcher M, Grazioli S, Koehler H, Perez MH, Trück J, Vanoni F, Zimmermann P, Sanchez C, Bielicki JA, Schlapbach LJ; Swissped RECOVERY Trial Group. Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial. Lancet Child Adolesc Health. 2023 Feb | Lire le résumé |
| Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, Philippot Q, Buta S, et al. Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells. Nature [Internet]. 22 févr 2023 [cité 24 févr 2023]; Disponible sur: https://www.nature.com/articles/s41586-023-05736-y | Lire le résumé |
| Batu ED, Günalp A, Şahin S, Özdel S, Kızıldağ Z, Pac Kısaarslan A, Bağrul İ, Kasap Cuceoglu M, Tanatar A, Sonmez HE, Sag E, Demir S, Çelikel E, Cağlayan S, Çelikel Acar B, Sözeri B, Aktay Ayaz N, Bilginer Y, Poyrazoğlu MH, Ünsal E, Kasapçopur Ö, Özen S. Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study. Rheumatol Int. 2023 Mar 12. doi: 10.1007/s00296-023-05300-x. Epub ahead of print. PMID: 36906866 | Lire le résumé |
| Boussard C, Delage L, Gajardo T, Kauskot A, Batignes M, Goudin N, Stolzenberg MC, Brunaud C, Panikulam P, Riller Q, Moya-Nilges M, Solarz J, Reperant C, Durel B, Bordet JC, Pellé O, Lebreton C, Magerus-Chatinet A, Pirabakaran V, Vargas P, Dupichaud S, Jeanpierre M, Vinit A, Zarhrate M, Masson C, Aladjidi N, Arkwright PD, Bader-Meunier B, Baron Joly S, Benadiba J, Bernard E, Berrebi D, Bodemer C, Castelle M, Charbit-Henrion F, Chbihi M, Debray A, Drabent P, Fraitag S, Hié M, Landman-Parker J, Lhermitte L, Moshous D, Rohrlich P, Ruemmele FM, Welfringer-Morin A, Tusseau M, Belot A, Cerf-Bensussan N, Roelens M, Picard C, Neven B, Fischer A, Callebaut I, Ménager MM, Sepulveda FE, Adam F, Rieux-Laucat F. DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity. Blood. 2023 Mar 23:blood.2022018486. doi: 10.1182/blood.2022018486. Epub ahead of print. PMID: 36952639. | Lire le résumé |
| Baghdassarian H, Blackstone SA, Clay OS, Philips R, Matthiasardottir B, Nehrebecky M, Hua VK, McVicar R, Liu Y, Tucker SM, Randazzo D, Deuitch N, Rosenzweig S, Mark A, Sasik R, Fisch KM, Pimpale Chavan P, Eren E, Watts NR, Ma CA, Gadina M, Schwartz DM, Sanyal A, Werner G, Murdock DR, Horita N, Chowdhury S, Dimmock D, Jepsen K, Remmers EF, Goldbach-Mansky R, Gahl WA, O'Shea JJ, Milner JD, Lewis NE, Chang J, Kastner DL, Torok K, Oda H, Putnam CD, Broderick L. Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome. N Engl J Med. 2023 Jun 15;388(24):2241-2252. doi: 10.1056/NEJMoa2202318. Epub 2023 May 31. PMID: 37256972. | Lire le résumé |
| Choi S, Choi HS, Ryu YJ, Kim JY, Paik JH, Ahn S, Lee H. Characterization of Kikuchi-Fujimoto Disease in Children and Risk Factors Associated with Its Course. J Pediatr. 2023 May 25;260:113515. doi: 10.1016/j.jpeds.2023.113515. Epub ahead of print. PMID: 37244579. | Lire le résumé |
| Hysa E, Pizzorni C, Sammorì S, Gotelli E, Cere A, Schenone C, et al. Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging. RMD Open. juill 2023;9(3):e003071. | Lire le résumé |
| Mankikian J, Caille A, Reynaud-Gaubert M, Agier MS, Bermudez J, Bonniaud P, et al. Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial. Eur Respir J. juin 2023;61(6):2202071. | Lire le résumé |
| Mascaro JM, Rodriguez-Pinto I, Poza G, Mensa-Vilaro A, Fernandez-Martin J, Caminal-Montero L, et al. Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism. Ann Rheum Dis. 4 sept 2023;ard-2023-224460 | Lire le résumé |
| Sánchez-Hernández BE, Calderón-Espinoza I, Martín-Nares E. Challenging the paradigm: a case of early-onset VEXAS syndrome. Rheumatology. 22 sept 2023;kead506 | Lire le résumé |
| Schett G, Mackensen A, Mougiakakos D. CAR T-cell therapy in autoimmune diseases. Lancet Lond Engl. 22 sept 2023;S0140-6736(23)01126-1. | Lire le résumé |
| Keum H, Bermas B, Patel S, Jacobe HT, Chong BF. Patients with autoimmune skin diseases are at increased risk of adverse pregnancy outcomes. Am J Obstet Gynecol MFM. 14 nov 2023;6(1):101226. | Lire le résumé |
| Johnson SR, Bernstein EJ, Bolster MB, Chung JH, Danoff SK, George MD, et al. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. août 2024;76(8):1182‑200. | Lire le résumé |
| Maccora I,, Soldovieri S, Oliverio T, de Masi S, Marrani E, Pagnini I, et al. To switch or to swap? Evidence from a meta-analysis for the best treatment approach in childhood chronic uveitis resistant to the I anti- TNF. J Transl Autoimmun. déc 2024;9:100247. | Lire le résumé |
| Hagen M, Bucci L, Böltz S, Nöthling DM, Rothe T, Anoshkin K, et al. BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease. N Engl J Med. 5 sept 2024;391(9):867‑9 | Lire le résumé |